Berapa harga Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Harga Reviva Pharmaceuticals Holdings, Inc. (RVPHW) adalah $0.003

Apa kapitalisasi pasar Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Kapitalisasi pasar Reviva Pharmaceuticals Holdings, Inc. (RVPHW) adalah $343.91K

Pendapatan Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for diseases with substantial unmet medical needs. Their pipeline targets disorders within the central nervous system, respiratory, cardiovascular, metabolic, and inflammatory disease categories. The company's leading drug candidate, brilaroxazine (RP5063), is currently in Phase III clinical trials for the treatment of schizophrenia. This compound has also completed Phase I trials for a diverse set of conditions, including bipolar disorder, major depressive disorder, attention-deficit/hyperactivity disorder, the behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. Furthermore, Reviva is advancing RP1208, which is in pre-clinical development for depression and obesity. Founded in 2018, the company is headquartered in Cupertino, California.

Tahun	Laba	Mengubah
Tidak cukup data untuk tanggal yang disediakan.

Tahun

Laba

Mengubah

Tidak cukup data untuk tanggal yang disediakan.

Perusahaan	Laba	Perbedaan Laba	Negara
Vertex Pharmaceuticals Incorporated VRTX.US	$5.27B	-	US
Argenx SE ARGX.US	$1.95B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$3.01B	-	BE

Perusahaan

Laba

Perbedaan Laba

Negara